Regulatory Affairs Professionals Society
- Jan 13, 2017
- 1 min read

Analysis: Longer Review Times Associated With Fewer Adverse Events for High-Risk Heart Devices

A new analysis finds longer regulatory review times for high-risk cardiovascular medical devices to be associated with fewer adverse event reports, and a lower likelihood of such reports citing serious injury or death.

The analysis, published in Nature Biomedical Engineering on Friday, raises questions about the trade-offs between speeding access to new devices and ensuring their safety.

Read the full article here.

#News

Recent Posts

See All

USA Patient Network Joins Patient Advocates in Joint Response to FDA Regarding Materials Used in Im

How the FDA Handles Recalls of Life-Saving Implants Could Put People at Risk, Patients Say

Jonesboro resident Geraldine Robinson is one of millions of Americans who use an implanted medical device to improve, and possibly extend her life. In 2013 she was implanted with a defibrillator to he

USA Patient Network Responds to Right To Try Legislation

We believe that there is no need for the proposed Right To Try Legislation (RTT). A pathway to such access already exists through the FDA’s